https://www.selleckchem.com/pr....oducts/l-dehydroasco
Chromophobe renal cell carcinoma (ChRCC) is a rare subtype of non-clear cell renal cell carcinoma. Due to its rarity, its molecular characterization as well as therapeutic targets are still not fully understood. We performed a next-generation sequencing analysis using the platform Ion PGM System on 20 retrospectively collected ChRCC cases with the aim of identify molecular biomarkers with potential prognostic value or that could have therapeutic implications. We identified mutation onTP53, SMARCB1, RB1 and JAK3. The most
Like
Comment
Share
